Medidata Expands Collaboration with CTI Clinical Trial and Consulting, Shaping a New Era of Patient-Centric Studies

Medidata Patient Experience will accelerate CTI’s treatments for patients with oncology, metabolic, cardiovascular, central nervous system, and immune conditions

New York – Nov. 4, 2025 – Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, and CTI Clinical Trial and Consulting (CTI), a global leader in research services for advanced therapies, have expanded their 12-year relationship. The new agreement places the Medidata Patient Experience and its essential, industry-leading solution, Medidata eCOA, at the heart of CTI’s patient-centric research and innovation, elevating data integrity and expediting the delivery of life-changing medicines.

Through this deepened collaboration, CTI is accredited in Medidata eCOA to further improve data collection capabilities, enhancing the clinical trial experience for patients by enabling the collection of real-time, high-quality data through easy-to-use digital applications. As a result, there will be seamless integration for both patients and study teams as Medidata eCOA will be working alongside Medidata Rave EDC – a solution already used by CTI – and other Medidata solutions on the Medidata Platform.  

“Achieving Medidata eCOA accreditation is a milestone that reflects CTI’s commitment to innovation and operational excellence. This capability allows us to deliver faster, more cost-effective solutions to our sponsors while maintaining the highest standards in data integrity and patient engagement. We’re thrilled to collaborate with Medidata to amplify this achievement,” said Sandy Miller, vice president, Global Biometrics.

“As our partnership continues to evolve, CTI will continue to capture high-quality insights and accelerate the flow of clinical data,” said Matt Noble, senior vice president, Patient Experience, Medidata. “CTI’s full accreditation in our eCOA empowers them to offer a more convenient and user-friendly way for patients to participate in trials while also providing the operational agility and data quality that sponsors demand.”

Medidata eCOA was recently named the highest Leader in the Everest Group’s PEAK Matrix® Assessment for eCOA.

The Medidata Patient Experience provides an end-to-end, AI-powered technology solution at every stage of the clinical trial journey, from recruitment to study completion. To learn more, please visit here.